Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F6BY1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,571
Award facts
- Contract value 100% obligated
- $7,570.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $7,570.74 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Xeljanz XR 11 mg tablets (30-count units). This competitively awarded, firm fixed-price contract contains no set-aside designation and requires completion by November 6, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Xeljanz XR is a prescription medication used primarily for rheumatoid arthritis and other inflammatory conditions, representing routine pharmaceutical procurement to support federal healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support platform. As a leading pharmaceutical distributor, AmerisourceBergen Drug Corp fulfills critical medical supply requirements across multiple therapeutic domains for military healthcare systems and other federal agencies through this prime contract vehicle. The company's extensive federal contracting history demonstrates its capability to meet demanding procurement specifications and delivery timelines across diverse pharmaceutical product categories.
Quick answers
Who was awarded contract SPE2DR26F6BY1?
SPE2DR26F6BY1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F6BY1 worth?
The government has obligated $7,571 on SPE2DR26F6BY1.
Is contract SPE2DR26F6BY1 an order under another contract?
Yes. SPE2DR26F6BY1 is a delivery order under SPE2DR25D1052, an indefinite delivery contract.
Was contract SPE2DR26F6BY1 competed?
The extent of competition for SPE2DR26F6BY1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award